Lucas P Neff1, Jeremy W Cannon, Jonathan J Morrison, Mary J Edwards, Philip C Spinella, Matthew A Borgman. 1. From the Department of Surgery (L.P.N.), David Grant Medical Center, Travis Air Force Base, Fairfield, California; Departments of Surgery (J.W.C., M.J.E.) and Pediatrics (M.A.B.), San Antonio Military Medical Center, Fort Sam Houston, San Antonio, Texas; Department of Surgery (L.P.N., J.W.C.), Uniformed Services University of the Health Sciences, Bethesda, Maryland; and Department of Pediatrics (P.C.S.), Washington University School of Medicine, St. Louis, Missouri; and The Academic Department of Military Surgery and Trauma (J.J.M.), Royal Centre for Defence Medicine, Birmingham, United Kingdom.
Abstract
BACKGROUND: Massive transfusion (MT) in pediatric patients remains poorly defined. Using the largest existing registry of transfused pediatric trauma patients, we sought a data-driven MT threshold. METHODS: The Department of Defense Trauma Registry was queried from 2001 to 2013 for pediatric trauma patients (<18 years). Burns, drowning, isolated head injury, and missing Injury Severity Score (ISS) were excluded. MT was evaluated as a weight-based volume of all blood products transfused in the first 24 hours. Mortality at 24 hours and in the hospital was calculated for increasing transfusion volumes. Sensitivity and specificity curves for predicting mortality were used to identify an optimal MT threshold. Patients above and below this threshold (MT+ and MT-, respectively) were compared. RESULTS: The Department of Defense Trauma Registry yielded 4,990 combat-injured pediatric trauma patients, of whom 1,113 were transfused and constituted the study cohort. Sensitivity and specificity for 24-hour and in-hospital mortality were optimal at 40.1-mL/kg and 38.6-mL/kg total blood products in the first 24 hours, respectively. With the use of a pragmatic threshold of 40 mL/kg, patients were divided into MT+ (n = 443) and MT- (n = 670). MT+ patients were more often in shock (68.1% vs. 47.0%, p < 0.001), hypothermic (13.0% vs. 3.4%, p < 0.001), coagulopathic (45.0% vs. 29.6%, p < 0.001), and thrombocytopenic (10.6% vs. 5.0%, p = 0.002) on presentation. MT+ patients had a higher ISS, more mechanical ventilator days, and longer intensive care unit and hospital stay. MT+ was independently associated with an increased 24-hour mortality (odds ratio, 2.50; 95% confidence interval, 1.28-4.88; p = 0.007) and in-hospital mortality (odds ratio, 2.58; 95% confidence interval, 1.70-3.92; p < 0.001). CONCLUSION: Based on this large cohort of transfused combat-injured pediatric patients, a threshold of 40 mL/kg of all blood products given at any time in the first 24 hours reliably identifies critically injured children at high risk for early and in-hospital death. This evidence-based definition will provide a consistent framework for future research and protocol development in pediatric resuscitation. LEVEL OF EVIDENCE: Diagnostic study, level II. Prognostic/epidemiologic study, level III.
BACKGROUND: Massive transfusion (MT) in pediatric patients remains poorly defined. Using the largest existing registry of transfused pediatric traumapatients, we sought a data-driven MT threshold. METHODS: The Department of Defense Trauma Registry was queried from 2001 to 2013 for pediatric traumapatients (<18 years). Burns, drowning, isolated head injury, and missing Injury Severity Score (ISS) were excluded. MT was evaluated as a weight-based volume of all blood products transfused in the first 24 hours. Mortality at 24 hours and in the hospital was calculated for increasing transfusion volumes. Sensitivity and specificity curves for predicting mortality were used to identify an optimal MT threshold. Patients above and below this threshold (MT+ and MT-, respectively) were compared. RESULTS: The Department of Defense Trauma Registry yielded 4,990 combat-injured pediatric traumapatients, of whom 1,113 were transfused and constituted the study cohort. Sensitivity and specificity for 24-hour and in-hospital mortality were optimal at 40.1-mL/kg and 38.6-mL/kg total blood products in the first 24 hours, respectively. With the use of a pragmatic threshold of 40 mL/kg, patients were divided into MT+ (n = 443) and MT- (n = 670). MT+patients were more often in shock (68.1% vs. 47.0%, p < 0.001), hypothermic (13.0% vs. 3.4%, p < 0.001), coagulopathic (45.0% vs. 29.6%, p < 0.001), and thrombocytopenic (10.6% vs. 5.0%, p = 0.002) on presentation. MT+patients had a higher ISS, more mechanical ventilator days, and longer intensive care unit and hospital stay. MT+ was independently associated with an increased 24-hour mortality (odds ratio, 2.50; 95% confidence interval, 1.28-4.88; p = 0.007) and in-hospital mortality (odds ratio, 2.58; 95% confidence interval, 1.70-3.92; p < 0.001). CONCLUSION: Based on this large cohort of transfused combat-injured pediatric patients, a threshold of 40 mL/kg of all blood products given at any time in the first 24 hours reliably identifies critically injured children at high risk for early and in-hospital death. This evidence-based definition will provide a consistent framework for future research and protocol development in pediatric resuscitation. LEVEL OF EVIDENCE: Diagnostic study, level II. Prognostic/epidemiologic study, level III.
Authors: Jeannie L Callum; Calvin H Yeh; Andrew Petrosoniak; Mark J McVey; Stephanie Cope; Troy Thompson; Victoria Chin; Keyvan Karkouti; Avery B Nathens; Kimmo Murto; Suzanne Beno; Jacob Pendergrast; Andrew McDonald; Russell MacDonald; Neill K J Adhikari; Asim Alam; Donald Arnold; Lee Barratt; Andrew Beckett; Sue Brenneman; Hina Razzaq Chaudhry; Allison Collins; Margaret Harvey; Jacinthe Lampron; Clarita Margarido; Amanda McFarlan; Barto Nascimento; Wendy Owens; Menaka Pai; Sandro Rizoli; Theodora Ruijs; Robert Skeate; Teresa Skelton; Michelle Sholzberg; Kelly Syer; Jami-Lynn Viveiros; Josee Theriault; Alan Tinmouth; Rardi Van Heest; Susan White; Michelle Zeller; Katerina Pavenski Journal: CMAJ Open Date: 2019-09-03
Authors: Elissa K Butler; Brianna M Mills; Saman Arbabi; Eileen M Bulger; Monica S Vavilala; Jonathan I Groner; Lynn G Stansbury; John R Hess; Frederick P Rivara Journal: Crit Care Med Date: 2019-07 Impact factor: 7.598
Authors: Robert Russell; David F Bauer; Susan M Goobie; Thorsten Haas; Marianne E Nellis; Daniel K Nishijima; Adam M Vogel; Jacques Lacroix Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.624
Authors: A Francois Trappey; Kyle M Thompson; Nathan Kuppermann; Jacob T Stephenson; Miriam A Nuno; Hilary A Hewes; Sage R Meyers; Rachel M Stanley; Joseph M Galante; Daniel K Nishijima Journal: J Trauma Acute Care Surg Date: 2019-10 Impact factor: 3.313
Authors: Julie C Leonard; Cassandra D Josephson; James F Luther; Stephen R Wisniewski; Christine Allen; Fabrizio Chiusolo; Adrienne L Davis; Robert A Finkelstein; Julie C Fitzgerald; Barbara A Gaines; Susan M Goobie; Sheila J Hanson; Hilary A Hewes; Laurie H Johnson; Mark O McCollum; Jennifer A Muszynski; Alison B Nair; Robert B Rosenberg; Thomas M Rouse; Athina Sikavitsas; Marcy N Singleton; Marie E Steiner; Jeffrey S Upperman; Adam M Vogel; Hale Wills; Margaret K Winkler; Philip C Spinella Journal: Crit Care Med Date: 2021-11-01 Impact factor: 9.296